Bromantane information

Bromantane
Clinical data
Trade names	Ladasten
Other names	Bromantan; Bromontan; ADK-709; Adamantylbromphenylamine
Routes of; administration	Oral (tablets)
ATC code	None;
Legal status
Legal status	US: Unscheduled not FDA approved; Rx-only (RU);
Pharmacokinetic data
Bioavailability	27.5%
Elimination half-life	11.21 hours (in humans),; 7 hours (in rats)
Identifiers
	IUPAC name N-(4-Bromophenyl)adamantan-2-amine;
CAS Number	87913-26-6 ;
PubChem CID	4660557;
ChemSpider	3849628 ;
UNII	N1ILS53XWK;
CompTox Dashboard (EPA)	DTXSID40405333 ;
ECHA InfoCard	100.213.907
Chemical and physical data
Formula	C16H20BrN
Molar mass	306.247 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1C2CC3CC1CC(C2)C3NC4=CC=C(C=C4)Br;
	InChI InChI=1S/C16H20BrN/c17-14-1-3-15(4-2-14)18-16-12-6-10-5-11(8-12)9-13(16)7-10/h1-4,10-13,16,18H,5-9H2 ; Key:LWJALJDRFBXHKX-UHFFFAOYSA-N ;
	(what is this?) (verify)

Bromantane, sold under the brand name Ladasten, is an atypical psychostimulant and anxiolytic drug of the adamantane family related to amantadine and memantine which is used in Russia in the treatment of neurasthenia. Although the effects of the bromantane have been determined to be dependent on the dopaminergic and possibly serotonergic neurotransmitter systems, its exact mechanism of action is unknown,^[3]^[4] and it is distinct in its properties relative to typical psychostimulants such as amphetamine. Because of its unique aspects, bromantane has sometimes been described instead as an actoprotector.^[5]^[6]

^ "Ladasten (adamantylbromphenylamine) Tablets for Oral Use. Full Prescribing Information". Russian State Register of Medicines (in Russian). Lekko CJSC. p. 1. Archived from the original on 3 February 2016. Retrieved 27 January 2016.
^ Neild PJ, Gazzard BG (September 1997). "HIV-1 infection in China". Lancet. 350 (9082): 963. doi:10.1016/S0140-6736(05)63309-0. PMID 9314899. S2CID 40317188.
^ Grekhova TV, Gainetdinov RR, Sotnikova TD, Krasnykh LM, Kudrin VS, Sergeeva SA, Morozov IS (1995). "Effect of bromantane, a new immunostimulating agent with psychostimulating activity, on the release and metabolism of dopamine in the striatum of freely moving rats. A microdialysis study". Bulletin of Experimental Biology and Medicine. 119 (3): 294–296. doi:10.1007/BF02445840. ISSN 0007-4888. S2CID 33214442.
^ Iezhitsa IN, Spasov AA, Bugaeva LI (2001). "Effects of bromantan on offspring maturation and development of reflexes". Neurotoxicology and Teratology. 23 (2): 213–222. doi:10.1016/S0892-0362(01)00119-2. PMID 11348840.
^ Spasov AA, Khamidova TV, Bugaeva LI, Morozov IS (2000). "Adamantane derivatives: Pharmacological and toxicological properties (review)". Pharmaceutical Chemistry Journal. 34 (1): 1–7. doi:10.1007/BF02524549. ISSN 0091-150X. S2CID 41620120.
^ Morozov IS, Ivanova IA, Lukicheva TA (2001). "Actoprotector and Adaptogen Properties of Adamantane Derivatives (A Review)". Pharmaceutical Chemistry Journal. 35 (5): 235–238. doi:10.1023/A:1011905302667. ISSN 0091-150X. S2CID 29475883.

[PI-1] "Ladasten (adamantylbromphenylamine) Tablets for Oral Use. Full Prescribing Information". Russian State Register of Medicines (in Russian). Lekko CJSC. p. 1. Archived from the original on 3 February 2016. Retrieved 27 January 2016.

[NeildGazzard1997-2] Neild PJ, Gazzard BG (September 1997). "HIV-1 infection in China". Lancet. 350 (9082): 963. doi:10.1016/S0140-6736(05)63309-0. PMID 9314899. S2CID 40317188.

[GrekhovaGainetdinov1995-3] Grekhova TV, Gainetdinov RR, Sotnikova TD, Krasnykh LM, Kudrin VS, Sergeeva SA, Morozov IS (1995). "Effect of bromantane, a new immunostimulating agent with psychostimulating activity, on the release and metabolism of dopamine in the striatum of freely moving rats. A microdialysis study". Bulletin of Experimental Biology and Medicine. 119 (3): 294–296. doi:10.1007/BF02445840. ISSN 0007-4888. S2CID 33214442.

[IezhitsaSpasov2001-4] Iezhitsa IN, Spasov AA, Bugaeva LI (2001). "Effects of bromantan on offspring maturation and development of reflexes". Neurotoxicology and Teratology. 23 (2): 213–222. doi:10.1016/S0892-0362(01)00119-2. PMID 11348840.

[SpasovKhamidova2000-5] Spasov AA, Khamidova TV, Bugaeva LI, Morozov IS (2000). "Adamantane derivatives: Pharmacological and toxicological properties (review)". Pharmaceutical Chemistry Journal. 34 (1): 1–7. doi:10.1007/BF02524549. ISSN 0091-150X. S2CID 41620120.

[MorozovIvanova2001-6] Morozov IS, Ivanova IA, Lukicheva TA (2001). "Actoprotector and Adaptogen Properties of Adamantane Derivatives (A Review)". Pharmaceutical Chemistry Journal. 35 (5): 235–238. doi:10.1023/A:1011905302667. ISSN 0091-150X. S2CID 29475883.

Bromantane information

and 22 Related for: Bromantane information

Bromantane

Anxiolytic

Actoprotector

Cocaine

Methamphetamine

Dopaminergic

Adapromine

Adderall

MDMA

Crack cocaine

Phencyclidine

Dipentylone

Adamantane

Ginseng

Psychoactive drug

Modafinil

List of dopaminergic drugs

Caffeine

Alertness

Theophylline

Xanthine

Coca